LAVA Therapeutics N.V. (NASDAQ: LVTX)
$2.22
+0.1100 ( +5.21% ) 85.7K
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.
Market Data
Open
$2.22
Previous close
$2.11
Volume
85.7K
Market cap
$58.84M
Day range
$2.09 - $2.32
52 week range
$1.13 - $6.47
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Quarterly Reports | 1 | Jun 20, 2024 |
| 6-k | Quarterly Reports | 30 | Jun 06, 2024 |
| 6-k | Quarterly Reports | 4 | May 21, 2024 |
| 6-k | Quarterly Reports | 2 | Mar 21, 2024 |
| 20-f | Annual reports | 116 | Mar 20, 2024 |
| 6-k | Quarterly Reports | 4 | Nov 16, 2023 |
| 6-k | Quarterly Reports | 4 | Aug 22, 2023 |
| 6-k | Quarterly Reports | 45 | Aug 15, 2023 |